-
-
-
-
-
-
-
Gilead Sciences extends WHO partnership to fight visceral leishmaniasis
-
-
-
-
-
-
-
Gilead Sciences (GILD) call put ratio 1 call to 1.3 puts with a focus on May 8 weekly 135 calls into quarter results
-
-
-
-
-
-
-
TD Cowen on Gilead Sciences (GILD): 'We Are Excited By Gilead's Recent String Of Deals'
-
-
-
-
-
-
-
Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald on Yeztugo TRx Gains
-
-
-
-
-
-
-
Truist on Gilead Sciences (GILD): 'old Rush: $2B Deal for Ouro Adds I&I Strength with BCMAxCD3 TCE in Orphan Autoimmune Indications
-
-
-
-
-
-
-
BofA Securities Reiterates Buy Rating on Gilead Sciences (GILD) as weekly Yeztugo scripts accelerate
-
-
-
-
-
-
-
Truist Securities Downgrades Arcellx Inc. (ACLX) to Hold
-
412,157 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

